2022
DOI: 10.3389/fcvm.2022.790921
|View full text |Cite
|
Sign up to set email alerts
|

Melatonin Attenuates Dasatinib-Aggravated Hypoxic Pulmonary Hypertension via Inhibiting Pulmonary Vascular Remodeling

Abstract: Dasatinib treatment is approved as first-line therapy for chronic myeloid leukemia. However, pulmonary hypertension (PH) is a highly morbid and often fatal side-effect of dasatinib, characterized by progressive pulmonary vascular remodeling. Melatonin exerts strong antioxidant capacity against the progression of cardiovascular system diseases. The present work aimed to investigate the effect of melatonin on dasatinib-aggravated hypoxic PH and explore its possible mechanisms. Dasatinib-aggravated rat experiment… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 63 publications
1
4
0
Order By: Relevance
“…Increased ROS further reduces the synthesis of NO by inhibiting eNOS activity to aggravate vascular endothelial OS injury, which promotes the proliferation and migration of vascular smooth muscle cells and accelerates vascular remodeling. In our study, OS was found activated in both lung tissues of PAH rats and hypoxia-stimulated PMECs, which was consistent with data presented by Wang [ 23 ] and Yu [ 24 ]. After PHN-20 treatment, OS was signally repressed in both lung tissues of PAH rats and hypoxia-stimulated PMECs, implying that the alleviative effect of PHN-20 against PAH might be correlated with the inhibition of OS.…”
Section: Discussionsupporting
confidence: 93%
“…Increased ROS further reduces the synthesis of NO by inhibiting eNOS activity to aggravate vascular endothelial OS injury, which promotes the proliferation and migration of vascular smooth muscle cells and accelerates vascular remodeling. In our study, OS was found activated in both lung tissues of PAH rats and hypoxia-stimulated PMECs, which was consistent with data presented by Wang [ 23 ] and Yu [ 24 ]. After PHN-20 treatment, OS was signally repressed in both lung tissues of PAH rats and hypoxia-stimulated PMECs, implying that the alleviative effect of PHN-20 against PAH might be correlated with the inhibition of OS.…”
Section: Discussionsupporting
confidence: 93%
“…It has the capacity for proliferation, anti-inflammatory, and anti-apoptotic properties (Frungieri et al 2017). Melatonin is now used in many pathophysiological fields because of its ability to interact with cells from the immune and cardiovascular systems and its significant role in the regulation of glucose and metabolic disorders (Navarro-Alarc ón et al 2014; Cho et al 2021;Wang et al 2022b). Because of its ability to cross physiological barriers, such as the blood-testis barrier (Venditti et al 2021), exogenous melatonin can reach the testis in a certain concentration (Álvarez-Fernández et al 2023).…”
Section: Discussionmentioning
confidence: 99%
“…However, PPHN lambs treated with melatonin showed improved pulmonary vasodilation and decreased pulmonary arterial pressure, enhanced SOD and CAT expression, and decreased generation of superoxide anions and NADPH oxidases in RV [61,62]. In a rat model of hypoxic PH melatonin was shown to attenuate pulmonary pressure and vascular remodeling, decreasing XO activity, MDA levels, NOX4 expression, and increasing CAT, GPx and SOD activities [63].…”
Section: Melatoninmentioning
confidence: 96%